Alfuzosin 10mg + Tadalafil 2.5mg ER Tablets

Alfuzosin 10mg + Tadalafil 2.5mg is a fixed combination for lower urinary-tract symptoms associated with benign prostate enlargement. It combines two smooth-muscle-relaxing mechanisms to help urinary flow, frequency and hesitancy.
Take the extended-release tablet after the same meal each day and swallow it whole. Do not crush, chew or split it. This continuing urinary-symptom regimen is not a tablet to take repeatedly before sexual activity.
Alfuzosin reduces alpha-1-mediated muscle tone around the prostate and bladder outlet. Tadalafil inhibits PDE5, supporting cyclic-GMP-mediated smooth-muscle relaxation in the lower urinary tract.
Headache, dizziness, flushing, indigestion, nasal congestion, back pain or low blood pressure can occur. Fainting, sudden vision or hearing loss, or a painful erection lasting over four hours needs urgent care.
Do not combine with nitrate medicines, recreational nitrites or riociguat because blood pressure can fall dangerously. Do not add a separate tadalafil, sildenafil or another alpha-blocker. Heart disease, recent stroke, severe liver or kidney impairment and cataract-surgery plans are important before treatment.
May improve urinary flow and reduce bothersome urinary symptoms through complementary actions. It does not directly remove prostate tissue or treat prostate cancer.
Do not add one independently. The tablet already contains tadalafil, and extra PDE5 inhibition can increase headache, prolonged erections and low blood pressure.
Seek urgent care and tell the emergency team when tadalafil was last taken. Do not use a nitrate chest-pain medicine yourself because the combination can cause dangerous hypotension.
No. This fixed product is a continuing urinary-symptom treatment. On-demand erectile-dysfunction regimens use a different treatment plan.
Not necessarily. Both ingredients mainly change smooth-muscle tone. Their symptom benefit does not demonstrate a reduction in prostate size.
PDE5: an enzyme that breaks down cyclic GMP; Cyclic GMP: a signal promoting smooth-muscle relaxation; Lower urinary-tract symptoms: problems with urine storage or flow; Nitrates: blood-vessel-relaxing heart medicines that interact with tadalafil; Extended release: gradual delivery of medicine from a tablet; AR: Alfuzosin 10mg + Tadalafil 2.5mg أقراص ممتدة التحرر; FR: Alfuzosin 10mg + Tadalafil 2.5mg comprimés à libération prolongée; PT: Alfuzosin 10mg + Tadalafil 2.5mg comprimidos de libertação prolongada; ES: Alfuzosin 10mg + Tadalafil 2.5mg comprimidos de liberación prolongada; RU: Alfuzosin 10mg + Tadalafil 2.5mg таблетки пролонгированного высвобождения; ID: Alfuzosin 10mg + Tadalafil 2.5mg tablet lepas lambat; VI: Alfuzosin 10mg + Tadalafil 2.5mg viên nén giải phóng kéo dài; MS: Alfuzosin 10mg + Tadalafil 2.5mg tablet pelepasan berpanjangan; TL: Alfuzosin 10mg + Tadalafil 2.5mg tabletang may pinalawig na paglabas; ZH-SG: Alfuzosin 10mg + Tadalafil 2.5mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Alfuzosin 10mg + Tadalafil 2.5mg ER Tablets under Urology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Alfuzosin 10mg + Tadalafil 2.5mg ER Tablets